Novo Nordisk A/S ADR buy StockNews.com
Start price
21.12.24
/
50%
€84.00
Target price
21.12.25
-
Performance (%)
-50.95%
End price
22.12.25
€41.20
Summary
This prediction ended on 22.12.25 with a price of €41.20. The BUY prediction by StockNews_com for Novo Nordisk A/S ADR performed very badly with a performance of -50.95%. StockNews_com has a follow-up prediction for Novo Nordisk A/S ADR where he still thinks Novo Nordisk A/S ADR is a Buy. A total of €1.10 was paid as dividends for this prediction. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | -2.879% | -2.879% | -55.975% |
| iShares Core DAX® | -2,12 % | -7,97 % | -1,73 % |
| iShares Nasdaq 100 | -1,32 % | -0,07 % | 16,60 % |
| iShares Nikkei 225® | -0,32 % | -6,38 % | 25,63 % |
| iShares S&P 500 | -1,57 % | -1,97 % | 10,83 % |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Novo Nordisk A/S ADR
Stopped prediction by StockNews_com for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€102.50
14.12.24
14.12.24
-
14.12.25
14.12.25
-58.15%
15.12.25
15.12.25
